2 completed, 1 active not recruiting, 1 terminated. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Active not recruiting 1, Terminated 1 |
Follow Sly Syndrome: new trials by email Literature Review of Sly Syndrome trials Research Report on Sly Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of UX003 Recombinant Human Beta-Glucuronidase (rhGUS) Enzyme Replacement Treatment in Mucopolysaccharidosis Type 7, Sly Syndrome (MPS 7) Patients Less Than 5 Years of Age UX003 - Sly Syndrome, MPS VII | Phase 2 | Completed | Ultragenyx Pharmaceutical Inc | 8 | 2015-07-21 | 2019-10-30 |
| MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis Stem Cell Transplantation, IMD Preparative Regimen, Osteopetrosis Only Preparative Regimen - Mucopolysaccharidosis Disorders, Hurler Syndrome | Phase 2 | Active not recruiting | Masonic Cancer Center, University of Minnesota | 149 | 2014-07-10 | 2026-11-03 |
| Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders Campath-1H, Cyclophosphamide, Busulfan - Mucopolysaccharidosis, Hurler Syndrome | Phase 2 | Completed | Masonic Cancer Center, University of Minnesota | 46 | 2009-12-01 | 2018-02-05 |
| Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism Stem Cell Transplantation, Cyclophosphamide, Campath-1H - Hurler's Syndrome, Maroteaux-Lamy Syndrome | Phase 2 | Terminated | Masonic Cancer Center, University of Minnesota | 18 | 2008-03-01 | 2017-12-28 |
Mucopolysaccharidosis VII (4) · Aspartylglucosaminuria (3) · Fucosidosis (3) · Leukodystrophy, Globoid Cell (3) · Leukodystrophy, Metachromatic (3) · Mucopolysaccharidosis I (3) · Mucopolysaccharidosis VI (3) · Peroxisomal Disorders (3) · Sphingolipidoses (3) · alpha-Mannosidosis (3) · Mucopolysaccharidoses (2) · Mucopolysaccharidosis II (2) · Adrenoleukodystrophy (1) · Alpha-Methylacyl-CoA Racemase Deficiency (1) · Hereditary Diffuse Leukoencephalopathy with Spheroids (1)
Carbohydrate Metabolism, Inborn Errors (4) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4) · Connective Tissue Diseases (4) · Genetic Diseases, Inborn (4) · Mucinoses (4) · Nutritional and Metabolic Diseases (4) · Skin and Connective Tissue Diseases (4) · Brain Diseases (3) · Brain Diseases, Metabolic (3) · Brain Diseases, Metabolic, Inborn (3) · Central Nervous System Diseases (3) · Demyelinating Diseases (3) · Hereditary Central Nervous System Demyelinating Diseases (3) · Leukoencephalopathies (3) · Lipid Metabolism Disorders (3)
Stem Cell Transplantation (3) · Alemtuzumab (2) · Busulfan (2) · Cyclophosphamide (2) · Bone Marrow Transplantation (1) · Cyclosporine (1) · Mycophenolic Acid (1) · Regimen B (1) · vestronidase alfa (1)
Masonic Cancer Center, University of Minnesota (3) · Ultragenyx Pharmaceutical Inc (1)
United States (4) · Portugal (1) · Spain (1)
Paul Orchard, MD (2) · Paul Orchard, M.D. (1)
PMID 21586746, PMID 30467742, PMID 35331634, PMID 37415957
2015 (1)